Sanjeev Khindri
Known title: Chief Development OfficerCIK: 0002104932
Associated companies
Transaction History
| LQDA | ▼ Sell | Open Market | 84 | $6K | 7/13/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 1,101 | $79K | 7/13/2026 | View on chart |
| LQDA | ▼ Sell | Open Market | 4,134 | $271K | 6/8/2026 | View on chart |
| LQDA | ▲ Buy | Grant | 34,274 | $0 | 1/16/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Liquidia shares fall on patent court loss and analyst downgrades
Liquidia stock is down sharply after a court ruling regarding YUTREPIA patent access, which analysts say clouds the drug's future. Wells Fargo downgraded the stock to Equal-Weight and lowered its price target to $30, while other analysts also cut their targets. The stock is currently trading near its 52-week low, reflecting significant market concern over the legal outcome.
Liquidia shares fall on patent court loss and analyst downgrades. Liquidia stock is down sharply after a court ruling regarding YUTREPIA patent access, which analysts say clouds the drug's future. Wells Fargo downgraded the stock to Equal-Weight and lowered its price target to $30, while other analysts also cut their targets. The stock is currently trading near its 52-week low, reflecting significant market concern over the legal outcome.